GR3005461T3 - - Google Patents

Info

Publication number
GR3005461T3
GR3005461T3 GR920401783T GR920401783T GR3005461T3 GR 3005461 T3 GR3005461 T3 GR 3005461T3 GR 920401783 T GR920401783 T GR 920401783T GR 920401783 T GR920401783 T GR 920401783T GR 3005461 T3 GR3005461 T3 GR 3005461T3
Authority
GR
Greece
Prior art keywords
loweralkyl
hydrogen
compounds
arylloweralkyl
proviso
Prior art date
Application number
GR920401783T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005461T3 publication Critical patent/GR3005461T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
GR920401783T 1986-11-24 1992-08-20 GR3005461T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/934,038 US4753950A (en) 1986-11-24 1986-11-24 Fused heterocyclic tetrahydroaminoquinolinols and related compounds

Publications (1)

Publication Number Publication Date
GR3005461T3 true GR3005461T3 (el) 1993-05-24

Family

ID=25464855

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401783T GR3005461T3 (el) 1986-11-24 1992-08-20

Country Status (17)

Country Link
US (1) US4753950A (el)
EP (1) EP0273176B1 (el)
JP (1) JPS63141980A (el)
KR (1) KR880006203A (el)
AT (1) ATE77625T1 (el)
AU (1) AU604786B2 (el)
DE (1) DE3780015T2 (el)
DK (1) DK613687A (el)
ES (1) ES2051723T3 (el)
FI (1) FI875145A (el)
GR (1) GR3005461T3 (el)
IL (1) IL84564A (el)
NO (1) NO167863C (el)
NZ (1) NZ222640A (el)
PH (1) PH25317A (el)
PT (1) PT86197B (el)
ZA (1) ZA878763B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851536A (en) * 1987-05-07 1989-07-25 American Home Products Corporation Cyclohexylquinolines as inhibitors of interleukin 1
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives
US5202440A (en) * 1987-10-05 1993-04-13 Pfizer Inc. Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or 1,2,3,4,5,6,7,8-octahydro-acridines
US5008853A (en) 1987-12-02 1991-04-16 Xerox Corporation Representation of collaborative multi-user activities relative to shared structured data objects in a networked workstation environment
DE3889302T2 (de) 1987-12-03 1994-10-20 Mitsubishi Chem Ind 9-(Acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde Mittel davon als aktiver Wirkstoff.
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
CA2029497C (en) * 1989-11-08 2002-06-04 Kunihiro Ninomiya (Deceased) 4-acylaminopyridine derivative
US5608067A (en) * 1993-12-09 1997-03-04 Afonso; Adriano 4-substituted pyrazoloquinoline derivatives
US5786480A (en) * 1994-04-28 1998-07-28 Schering Corporation 4-substituted pyrazoloquinoline derivatives
KR101953366B1 (ko) 2018-12-26 2019-02-28 정종문 침향을 포함하는 기억력 및 인지능력을 향상시키는 기능성 건강식품 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8329531D0 (en) * 1983-11-04 1983-12-07 Ici America Inc Pyrazolopyridine cycloalkanones
ATE63903T1 (de) * 1984-10-25 1991-06-15 Hoechst Roussel Pharma 9-amino-1,2,3,4-tetrahydroacridin-1-ol und verwandte verbindungen, verfahren zu ihrer herstellung und verwendung als arzneimittel.
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives

Also Published As

Publication number Publication date
ES2051723T3 (es) 1994-07-01
NO167863B (no) 1991-09-09
DE3780015T2 (de) 1993-01-21
EP0273176B1 (en) 1992-06-24
FI875145A0 (fi) 1987-11-20
JPS63141980A (ja) 1988-06-14
PT86197B (pt) 1990-11-07
DK613687D0 (da) 1987-11-23
DE3780015D1 (de) 1992-07-30
PH25317A (en) 1991-04-30
AU8148387A (en) 1988-05-26
PT86197A (en) 1987-12-01
EP0273176A2 (en) 1988-07-06
DK613687A (da) 1988-05-25
NO874872D0 (no) 1987-11-23
ATE77625T1 (de) 1992-07-15
AU604786B2 (en) 1991-01-03
NZ222640A (en) 1990-10-26
FI875145A (fi) 1988-05-25
IL84564A (en) 1993-03-15
ZA878763B (en) 1988-05-19
EP0273176A3 (en) 1988-07-20
NO167863C (no) 1991-12-18
US4753950A (en) 1988-06-28
NO874872L (no) 1988-05-25
KR880006203A (ko) 1988-07-22
IL84564A0 (en) 1988-04-29

Similar Documents

Publication Publication Date Title
PH25571A (en) Alpha'-alkyl-4-amino-3-quinolinemethanols, 1-(4-aralkylamino-3-quinolinyl) alaknones, their use as medicaments
IL96209A0 (en) 4-and 6-carbamates related to physostigmine,a process for their preparation and their use as medicaments
ATE101140T1 (de) Substituierte cycloalkanole.
GR3005461T3 (el)
HU912786D0 (en) Process for producing 4-substituted-dihydro-pyrido(4,3-d) pyrimidine derivatives as well as pharmaceutical preparatives containing said compounds
ES2064533T3 (es) Acido(1,2,3,4-tetrahidro-9-acridinimino)-ciclohexanocarboxilico y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos.
IE902078L (en) 4,5,5a,6-Tetrahydro-3H-isoxazolo£5,4,3-k1|acridines¹derivatives, a process for their preparation and their use¹as medicaments